|
MNPR Monopar Therapeutics Inc 1645469 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-5,313,300.00 |
| Balance Sheet |
|
Current Assets
|
$134,763,709.00 |
|
Assets
|
$134,978,829.00 |
|
Current Liabilities
|
$4,016,031.00 |
|
Liabilities
|
$4,123,859.00 |
|
Equity
|
$130,854,970.00 |
|
Shares Out
|
6712172.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,721,343.00 |
|
Investing Cash Flow
|
$-1,468,080.00 |
| Market Analysis |
Market Cap
|
$744,245,631.36 |
|
Price
|
$110.88 |
|
BVPS
|
19.50 |
|
PB
|
5.69 |
|
EPS
|
-0.62 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:31 |
|
| Apr |
May |
Jun |
| 2026-03-27 |
-0.61 |
|
|
2026-05-14 |
-0.46 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.48 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MNPR documents filed with the SEC.
MNPR Filings
Clear
